Urology News and Research

Latest Urology News and Research

Metabolic syndrome increases erectile dysfunction risk

The metabolic syndrome is an independent risk factor for the development of erectile dysfunction in Chinese men, especially among those who are middle-aged, show study findings.

29 Oct 2012

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.

29 Oct 2012

FDA approves Watson’s generic Actos

Watson Pharmaceuticals, Inc. today announced that Watson has launched a generic version of Actos (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets) after receiving final approval today from the U.S. Food and Drug Administration (FDA).

29 Oct 2012

NAFC conducts online survey to examine women’s perceptions about overactive bladder

The National Association For Continence (NAFC) is conducting an anonymous online survey to understand the perceptions women, age 40-65, have about overactive bladder (OAB) and what they are prepared to do about its symptoms. Using constructs from the Health Belief Model, this survey aims to explain the fears and preparedness women have towards general health and OAB. This research is conducted by Kelton Global Research, a market research company and supported by a grant from Merck Pharmaceuticals.

26 Oct 2012

Online resource for men diagnosed with low-grade prostate cancer launched

Johns Hopkins Medicine, along with the Prostate Cancer Foundation and Cedars-Sinai Medical Center, have launched the National Proactive Surveillance Network, an online resource for men diagnosed with low-grade prostate cancer that can be slow-growing and non-life-threatening in up to 50 percent of diagnosed cases.

25 Oct 2012

New biomarker measures aggressiveness of primary prostate tumors

Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

24 Oct 2012

Large hospitals not following CAUTI preventive guidelines in their ICUs

Hospital size matters when it comes to intensive care units (ICUs) adopting even the most routine prevention policies for catheter-associated urinary tract infections (CAUTI), according to a new study from researchers at Columbia University School of Nursing, published this month in the American Journal of Infection Control.

24 Oct 2012

AUA introduces new guidelines for treatment of OAB, urodynamics, hematuria and vasectomy

The American Urological Association (AUA) introduces new clinical guidelines for the treatment of Overactive Bladder, Urodynamics, Hematuria, and Vasectomy.

24 Oct 2012

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

Informatics is integral to solving the nation's urgent healthcare issues of rising costs and the delivery of quality care. Training the next generation of professionals to develop, implement and research new informatics technologies is vital. Through the Weill Cornell Graduate School of Medical Sciences, the Center for Healthcare Informatics and Policy (CHiP) is now accepting applications for a new master's program in health informatics to do just that.

24 Oct 2012

Cardiovascular disease risk varies with HIV subgroup

The ability of lipids to predict risk for cardiovascular disease may be weakened in women who are infected with HIV, report researchers.

23 Oct 2012

Ambulatory surgery centers and physician offices less costly than hospitals

More and more outpatient surgical procedures are being done at nonhospital-based facilities such as freestanding ambulatory surgical centers and physician offices, instead of at hospital-based outpatient departments.

22 Oct 2012

Study identifies new risk factors for bladder cancer

Low depressive symptoms and a longer telomere length are compelling factors that contribute to a prolonged life for bladder cancer patients according to researchers at The University of Texas MD Anderson Cancer Center.

19 Oct 2012

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI.

19 Oct 2012

Long-term multivitamin use associated with prevention of cancer in middle-aged and older men

In a randomized trial that included nearly 15,000 male physicians, long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer after more than a decade of treatment and follow-up, according to a study appearing in JAMA.

19 Oct 2012

Reduced copayment policy has benefits all round

Reducing patients’ copayments for statins and clopidogrel could increase their adherence without adding financial burden to the healthcare system, researchers say.

18 Oct 2012

Health benefits of fibrate add-on detected postprandially

Adding fenofibrate to statin treatment significantly improves postprandial triglyceride response over statin treatment alone in individuals with diabetes, show findings from a US study.

18 Oct 2012

Botulinum treatment benefits in BPH maybe down to placebo effect

Treatment with botulinum toxin has proved no more effective than placebo at reducing symptoms in men with lower urinary tract symptoms due to benign prostate hyperplasia, show study findings.

17 Oct 2012

Stat5 protein could serve as biomarker to help guide prostate cancer treatment

Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent study published in Human Pathology by Jefferson's Kimmel Cancer Center researchers.

17 Oct 2012

Study identifies multipotent and unipotent stem cells that contribute to prostate postnatal development

Publication in Nature Cell Biology advanced on line publication: researchers at the Université Libre de Bruxelles, ULB identify multipotent and unipotent Stem Cells (SCs) that contribute to prostate postnatal development.

16 Oct 2012

Hospital payments will soon be tied in part to patient satisfaction

The Wall Street Journal reports that, in the year ahead, nearly $1 billion in payments to hospitals will be based in part on patient satisfaction.

16 Oct 2012

Urology News and Research

Latest Urology News and Research

Metabolic syndrome increases erectile dysfunction risk

Scientists identify mechanism via Top2b enzyme that drives doxorubicin-induced heart damage

FDA approves Watson’s generic Actos

NAFC conducts online survey to examine women’s perceptions about overactive bladder

Online resource for men diagnosed with low-grade prostate cancer launched

New biomarker measures aggressiveness of primary prostate tumors

Large hospitals not following CAUTI preventive guidelines in their ICUs

AUA introduces new guidelines for treatment of OAB, urodynamics, hematuria and vasectomy

Weill Cornell’s ChiP now accepts applications for new master's program in health informatics

Cardiovascular disease risk varies with HIV subgroup

Ambulatory surgery centers and physician offices less costly than hospitals

Study identifies new risk factors for bladder cancer

Active surveillance of small kidney masses offers similar cancer outcomes to radical or partial surgery

Long-term multivitamin use associated with prevention of cancer in middle-aged and older men

Reduced copayment policy has benefits all round

Health benefits of fibrate add-on detected postprandially

Botulinum treatment benefits in BPH maybe down to placebo effect

Stat5 protein could serve as biomarker to help guide prostate cancer treatment

Study identifies multipotent and unipotent stem cells that contribute to prostate postnatal development

Hospital payments will soon be tied in part to patient satisfaction

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in